Peripheral Nervous System Diseases: Clinical Trials

770 trials for Peripheral Nervous System Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

409 completed, 112 terminated, 71 unknown, 68 recruiting. 770 Phase 2, 123 Phase 1, 71 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 2770Completed 409, Terminated 112, Unknown 71, Recruiting 68, Withdrawn 41, Active not recruiting 31, Not yet recruiting 29, Suspended 5, Enrolling by invitation 4
Phase 1123Completed 56, Recruiting 24, Terminated 12, Active not recruiting 9, Withdrawn 8, Unknown 7, Not yet recruiting 4, Suspended 2, Enrolling by invitation 1
Phase 371Completed 34, Unknown 17, Terminated 9, Not yet recruiting 5, Recruiting 3, Withdrawn 3

Follow Peripheral Nervous System Diseases: new trials by email Literature Review of Peripheral Nervous System Diseases trials Research Report on Peripheral Nervous System Diseases

Trials (filtered) newest first · largest first

All 770 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ketamine and Midazolam Infusions for CRPS: Feasibility Study
Ketamine, Midazolam, Normal Saline - Complex Regional Pain Syndromes
Phase 2WithdrawnStanford University2099-01-012024-11-22
Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A
scAAV1.tMCK.NTF3 - Charcot-Marie-Tooth Neuropathy Type 1A
Phase 1 / Phase 2WithdrawnNationwide Children's Hospital2027-04-012026-07-29
Safety and Efficacy Study on AFA-281 for the Treatment of Low Back Pain
AFA-281 - Lumbosacral Radiculopathy
Phase 2Not yet recruitingAfasci Inc4082027-04-012025-06-26
Efficacy of Mirdametinib Alone or Combination With Radiotherapy for Germline and Sporadic NF1-Altered High-Grade Glioma
mirdametinib with radiation, mirdametinib - Neurofibromatosis 1 (NF1)
Phase 2Not yet recruitingUniversity of Alabama at Birmingham552027-01-012026-10-05
Ketamine HCl Prolonged Release Oral Tablets for CRPS
80mg/day Ketamine HCl Prolonged Release, 160mg/day Ketamine HCl Prolonged Release - Complex Regional Pain Syndromes
Phase 2SuspendedUniversity of Southern California652027-01-012026-07-27
Efficacy of Botulinum Toxin Versus Placebo on Pain and Health Related Quality of Life of Patients With Piriformis Muscle Syndrome
Botulinum Toxin - A injections, Placebo - Piriformis Muscle Syndrome
Phase 2Not yet recruitingCentre Hospitalier Universitaire de Nīmes1082027-01-012026-10-21
Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath Tumor
avutometinib capsule + defactinib tablet - MPNST (Malignant Peripheral Nerve Sheath Tumor)
Phase 2Not yet recruitingGirish Dhall, MD252027-01-012026-10-28
Aspirin and PAClitaxel in Head & Neck Squamous Cell Carcinoma
Aspirin, Paclitaxel - Head and Neck (HNSCC), Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
Phase 2Not yet recruitingWashington University School of Medicine402026-12-312026-10-28
Evaluation of the Effect of Amantadine in the Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients
Amantadine (oral) - Breast Cancer, Peripheral Neuropathy Due to Chemotherapy
Phase 2Not yet recruitingAl-Azhar University802026-12-012026-10-22
A Study of Empasiprubart as Add-On Therapy to IVIg in Adult Participants With Guillain-Barré Syndrome
Empasiprubart IV, Empasiprubart Placebo IV, Intravenous immunoglobulin (IVIg) - Guillain-Barré Syndrome (GBS)
Phase 2Not yet recruitingargenx632026-12-012026-10-28
4AP for Carpal Tunnel Syndrome (CTS)
4-Aminopyridine, Placebo - Compression Neuropathy, Carpal Tunnel Syndrome
Phase 2Not yet recruitingJohn Elfar1602026-11-012026-01-26
Perineural Botulinum Toxin Injection Versus Oral Duloxetine in Relief of Foot Pain in Painful Peripheral Diabetic Neuropathy
Botulinum Toxin Type A, Duloxetine, Oral Placebo Tablet - Diabetic Peripheral Neuropathy, Painful Diabetic Neuropathy
Phase 2Not yet recruitingAssiut University562026-11-012026-10-20
Clinical Efficacy of Acupuncture and Paraffin Wax Therapy in the Treatment of Carpal Tunnel Syndrome
Electroapuncture and paraffin wax therapy, Electropuncture, Paraffin wax therapy - Carpal Tunnel Syndrome (CTS)
Phase 2 / Phase 3Not yet recruitingThe University of Health Sciences, VNU-HCM1772026-11-012026-11-12
NAC-REPAIR for Post-surgical Pain
NAC, NAC 0mg/day (Placebo) - Carpal Tunnel Surgery, Trigger Finger Disorder
Phase 2Not yet recruitingUniversity of Arizona802026-10-152026-07-17
Safety and Efficacy Study of GEB-101 Injection in Subjects With TGFBI-related Corneal Dystrophy
GEB-101 Injection - Hereditary Corneal Dystrophy, Corneal Abnormality
Phase 1 / Phase 2Not yet recruitingGenEditBio Limited302026-10-012026-09-10
Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer
Desloratodine, Placebo - Breast Cancer, Peripheral Neuropathy
Phase 2RecruitingMontefiore Medical Center1162026-09-012026-08-26
Efficacy and Safety of Efgartigimod in the Treatment of Guillain-Barré Syndrome(GREAT)
Intravenous immunoglobulin (IVIG), Efgartigimod Alfa-Fcab - Guillain-Barré Syndrome
Phase 2Not yet recruitingBeijing Tiantan Hospital1102026-09-012026-09-18
A Study to Assess the Correct Dose, Safety and Efficacy of Empasiprubart in Adolescent Participants Aged 12 to Less Than 18 Years With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Empasiprubart IV - Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)
Phase 2 / Phase 3Withdrawnargenx2026-09-012026-11-13
Psilocybin to Treat Depression in Spinal Cord Injury
Psilocybin (Usona Institute) - Spinal Cord Injury, Depression - Major Depressive Disorder
Phase 1 / Phase 2RecruitingJames J. Peters Veterans Affairs Medical Center302026-08-062026-08-10
Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
Selumetinib + ZEN-3694 ± Durvalumab - MPNST, NF1
Phase 2RecruitingUniversity of Alabama at Birmingham412026-08-042026-08-24

Showing 20 of 770. Sign in to see all of them.

Narrower conditions

Neuralgia (174)  ·  Diabetic Neuropathies (119)  ·  Pain (82)  ·  Hereditary Sensory and Autonomic Neuropathies (75)  ·  Neuralgia, Postherpetic (68)  ·  Neurofibrosarcoma (57)  ·  Neurofibromatosis 1 (55)  ·  Sarcoma (42)  ·  Diabetes Mellitus (40)  ·  Carpal Tunnel Syndrome (33)  ·  Breast Neoplasms (31)  ·  Leiomyosarcoma (30)  ·  Sarcoma, Synovial (29)  ·  Neurofibroma, Plexiform (28)

Broader conditions

Nervous System Diseases (767)  ·  Neuromuscular Diseases (766)  ·  Pathological Conditions, Signs and Symptoms (360)  ·  Signs and Symptoms (299)  ·  Neurologic Manifestations (297)  ·  Pain (202)  ·  Neoplasms (195)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (191)  ·  Genetic Diseases, Inborn (182)  ·  Neurodegenerative Diseases (179)  ·  Heredodegenerative Disorders, Nervous System (175)  ·  Neoplasms by Histologic Type (157)  ·  Endocrine System Diseases (152)  ·  Polyneuropathies (147)

Interventions

Pregabalin (25)  ·  Saline Solution (17)  ·  AZD 6244 (14)  ·  Botulinum Toxins, Type A (12)  ·  Sodium Chloride (12)  ·  Lidocaine (11)  ·  Doxorubicin (10)  ·  Dexamethasone (9)  ·  Ketamine (9)  ·  Immunoglobulins, Intravenous (8)  ·  Acupuncture Therapy (7)  ·  Alpelisib (7)  ·  Duloxetine Hydrochloride (7)  ·  Everolimus (7)  ·  Lenalidomide (7)

Sponsors

National Cancer Institute (NCI) (20)  ·  Pfizer (15)  ·  Novartis Pharmaceuticals (11)  ·  AstraZeneca (10)  ·  Memorial Sloan Kettering Cancer Center (8)  ·  UCB Pharma (8)  ·  University of Alabama at Birmingham (8)  ·  Washington University School of Medicine (8)  ·  European Organisation for Research and Treatment of Cancer - EORTC (7)  ·  NYU Langone Health (7)  ·  NeurogesX (7)  ·  University Hospital, Clermont-Ferrand (7)  ·  Sangamo Therapeutics (6)  ·  Allergan (5)  ·  Children's Hospital Medical Center, Cincinnati (5)

Countries

United States (415)  ·  France (81)  ·  Germany (74)  ·  Canada (67)  ·  United Kingdom (62)  ·  Spain (56)  ·  Italy (43)  ·  China (39)  ·  Denmark (36)  ·  Netherlands (36)  ·  Poland (36)  ·  Australia (32)  ·  Belgium (28)  ·  Czechia (26)  ·  Japan (22)

Top investigators

Brigitte C Widemann, M.D. (5)  ·  AeRang Kim, MD, PhD (3)  ·  Angela Hansen (3)  ·  Aziz Shaibani, MD (3)

Results publications

PMID 28029918, PMID 31353964, PMID 32107748, PMID 32187457, PMID 15683544, PMID 17105749, PMID 18619874, PMID 21996156, PMID 22353803, PMID 24327518, PMID 25594611, PMID 26851632, PMID 27424289, PMID 27494299, PMID 28230061, PMID 28409229, PMID 28672195, PMID 29115008, PMID 29383130, PMID 29846250, PMID 30558645, PMID 31010905, PMID 31101621, PMID 31401903, PMID 31533931, PMID 31582003, PMID 31831767, PMID 31882719, PMID 31894292, PMID 33354735, PMID 33675631, PMID 33863389, PMID 34541874, PMID 35587172, PMID 38729747, PMID 10411196, PMID 10606379, PMID 10846153, PMID 11145807, PMID 11402097, PMID 11705489, PMID 11735667, PMID 11884154, PMID 12084892, PMID 12151246, PMID 12384756, PMID 12473512, PMID 12528778, PMID 12723749, PMID 12897484

NIH funding

2018 (8), 2016 (6), 2017 (6), 2019 (6), 2023 (6), 2014 (4), U10CA180886 (4), 2008 (3), 2009 (3), P30CA008748 (3), 2015 (2), 2025 (2), N01CM62206 (2), P30CA015083 (2), U10CA098543 (2)